Home / Market News / $OMCL

$OMCL news and market catalysts

The 4 most recent market catalysts affecting $OMCL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

4 catalysts 2 high impact 2 bullish 1 bearish Healthcare Technology
Aug 3, 2026 Corporate Catalyst Bearish Impact 55
Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45
Piper Sandler, a prominent investment bank, has reaffirmed its 'Overweight' rating on Omnicell, suggesting a belief in the company's long-term growth potential. However, the simult…
Jul 30, 2026 Corporate Catalyst Neutral Impact 92
Omnicell Sees Q3 Adj EPS $0.35-$0.43 vs $0.47 Est; Sees Sales $301.000M-$307.000M vs $312.528M Est
Omnicell (OMCL) has issued a pre-announcement for its Q3 financial outlook, projecting adjusted EPS of $0.35-$0.43 and sales of $301M-$307M. These figures are notably lower than th…
Jul 30, 2026 Corporate Catalyst Bullish Impact 75
Omnicell Raises FY2026 Adj EPS Guidance from $1.80-$2.00 to $2.15-$2.30 vs $1.94 Est; Narrows FY2026 Sales Guidance from $1.215B-$1.255B to $1.225B-$1.245B vs $1.248B Est
Omnicell (OMCL) has updated its financial guidance for fiscal year 2026. The company significantly increased its adjusted EPS guidance from $1.80-$2.00 to $2.15-$2.30, which is not…
Jul 30, 2026 Corporate Catalyst Bullish Impact 92
Omnicell Q2 Adj. EPS $0.94 Beats $0.47 Estimate, Sales $312.208M Beat $310.253M Estimate
Omnicell's Q2 earnings per share of $0.94 significantly surpassed the analyst consensus of $0.47, representing a 100% beat and a 108.89% increase year-over-year. Sales also beat es…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.